Identification of CTL epitope using mass spectrometer.
Project/Area Number |
23701079
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor immunology
|
Research Institution | Aichi Cancer Center Research Institute |
Principal Investigator |
OKAMURA Ayako 愛知県がんセンター(研究所), 腫瘍免疫学部, 研究員 (10546948)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 腫瘍免疫 / 細胞傷害性Tリンパ球 / オートファジー / 抗原提示 / がん / 免疫 / CTL / エピトープ / マススペクトロメトリー |
Research Abstract |
Cytotoxic T lymphocytes (CTLs) exert anti-tumor effects through recognition of tumor antigen-derived peptides bound to human leukocyte antigens (HLAs) on cell surfaces. To identify diverse CTL epitopes of tumor antigens, mass spectrometry-based approach are examined. To investigate CTL epitope panel through tumor-specific antigen presenting machinery, MCF10A cells were transduced mutated K-ras gene. As a result, the gene-modified MCF10A cells had constitutively active autophagosomes and produced autophagosome-dependent epitopes. These data suggest that the cells having tumor-specific antigen presenting machinery provide us information on various CTL epitopes processed through the machinery.
|
Report
(3 results)
Research Products
(11 results)